Skip to main content
. 2016 Jun 1;27:95–103. doi: 10.1007/s00399-016-0437-3

Fig. 1.

Fig. 1

Distribution of congenital heart disease (CHD) implantable cardioverter-defibrillator population by CHD lesion. Figures are adapted from the two largest population studies. The 1304 patients reported by Jordan et al with atrial septal defect (ASD) alone are excluded. No patients with VSD alone were reported by Berul et al [3, 13]